Hair disorders in cancer survivors

Azael Freites-Martinez, Jerry Shapiro, Corina van den Hurk, Shari Goldfarb, Joaquin J. Jimenez, Anthony M. Rossi, Ralf Paus, Mario E. Lacouture

Research output: Contribution to journalReview articlepeer-review


With increasing survival rates across all cancers, survivors represent a growing population that is frequently affected by persistent or permanent hair growth disorders as a result of systemic therapies, radiotherapy, surgical procedures, and therapeutic transplants. These hair disorders include persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, endocrine therapy–induced alopecia and hirsutism, postsurgery alopecia and localized hypertrichosis, and persistent stem cell transplantation and targeted therapy-induced alopecia. The information contained in this continuing medical education series should facilitate a better understanding on hair disorders in cancer survivors so that adequate support and therapies may be provided.

Original languageEnglish
Pages (from-to)1199-1213
Number of pages15
JournalJournal of the American Academy of Dermatology
Issue number5
Early online date14 Apr 2018
Publication statusPublished - 1 May 2019


  • alopecia
  • cancer survivors
  • cancer therapy
  • endocrine therapy
  • hirsutism
  • hypertrichosis
  • persistent alopecia
  • persistent chemotherapy-induced alopecia
  • persistent radiotherapy-induced alopecia
  • quality of life
  • therapeutic transplants


Dive into the research topics of 'Hair disorders in cancer survivors'. Together they form a unique fingerprint.

Cite this